The hospital software specialist NEXUS AG increased its sales by around 8 % and its EBIT by around 13 % in the first half of 2019. The NEXUS Group therefore continued its long-standing positive sales and earnings performance.
Sales climbed by 8.2 % from KEUR 64,446 (6M-2018) to KEUR 69,708 in the first half of 2019. Consolidated EBIT improved by 13.4 % to KEUR 7,488 (6M-2018: KEUR 6,605). EBITA climbed by 12.9 % from KEUR 8,194 (6M-2018) to KEUR 9,247. EBITDA rose by 25.6 % (adjusted for IFRS 16 effect: 8.7 %) to KEUR 15,417 (adjusted for IFRS 16 effect: KEUR 13,340) (6M-2018: KEUR 12,276). Consolidated net income is up by 2.6 % at KEUR 5,346 in the first half of 2019 after KEUR 5,212.
Operating cash amounted to KEUR 28,871 after the strong prior-year figure (6M-2018: KEUR 18,268). NEXUS AG had cash funds including current financial assets of KEUR 36,432 as of 30 June 2019 (30 June 2018: KEUR 25,129). A dividend of KEUR 2,676 (2018: KEUR 2,519) was paid to our stockholders in 2019. Earnings per share amounted to EUR 0.27 in the first half of the year (previous year: EUR 0.32).
NEXUS AG had equity of KEUR 109,081 as of 30 June 2019 (31 December 2018: KEUR 108,325). NEXUS AG therefore has a consistently healthy statement of financial position and sufficient capital to continue financing its European growth strategy.
The detailed Half-Year Report can be found on our homepage at:
https://en-en.nexus-ag.de/company/investor-relations - Financial Reports
|Contact Person:||Dr. Patrick Stein|
|Phone:||+49 771 22960-260|
|Stock Exchange(s):||Regulated Market in Frankfurt, Regulated Market in Hamburg, Free Market in Berlin, Free Market in Dusseldorf, Free Market in Munich, Free Market in Stuttgart|